NeoPharm CO. LTD (092730) — Net Asset Quality Index
NeoPharm CO. LTD (092730) has a Net Asset Quality Index of 90.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩207.38 Billion minus total liabilities of ₩18.97 Billion yields net assets of ₩188.40 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 092730 total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
NeoPharm CO. LTD Net Asset Quality Index Over Time (2012–2024)
This chart shows how NeoPharm CO. LTD's Net Asset Quality Index has evolved across 11 annual periods from 2012 to 2024. As of September 2025, the index stands at 90.9%, representing net assets of ₩188.40 Billion against total assets of ₩207.38 Billion KRW. For live market cap and overall valuation, see 092730 stock market capitalisation.
Annual Net Asset Quality Index for NeoPharm CO. LTD (2012–2024)
The table below presents the year-by-year Net Asset Quality Index for NeoPharm CO. LTD from 2012 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is NeoPharm CO. LTD's equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 91.9% | ₩176.88 Billion | ₩192.44 Billion | ₩15.56 Billion | ▲ +1.7 pp |
| 2023 | 90.2% | ₩160.03 Billion | ₩177.46 Billion | ₩17.43 Billion | ▼ -1.4 pp |
| 2022 | 91.5% | ₩142.21 Billion | ₩155.35 Billion | ₩13.14 Billion | ▲ +0.7 pp |
| 2021 | 90.9% | ₩130.30 Billion | ₩143.41 Billion | ₩13.10 Billion | ▲ +2.3 pp |
| 2020 | 88.5% | ₩117.72 Billion | ₩132.98 Billion | ₩15.26 Billion | ▲ +2.4 pp |
| 2019 | 86.1% | ₩105.69 Billion | ₩122.74 Billion | ₩17.05 Billion | ▲ +4.8 pp |
| 2018 | 81.3% | ₩59.29 Billion | ₩72.93 Billion | ₩13.64 Billion | ▼ -2.6 pp |
| 2017 | 83.9% | ₩47.58 Billion | ₩56.69 Billion | ₩9.11 Billion | ▲ +1.0 pp |
| 2016 | 82.9% | ₩38.57 Billion | ₩46.51 Billion | ₩7.94 Billion | ▲ +2.2 pp |
| 2015 | 80.7% | ₩32.62 Billion | ₩40.41 Billion | ₩7.79 Billion | ▼ -6.9 pp |
| 2012 | 87.6% | ₩29.92 Billion | ₩34.14 Billion | ₩4.22 Billion | — |